Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda
Background Immediate uptake of antiretroviral therapy (ART) after an HIV-positive diagnosis (Test and Treat) is now being implemented in Uganda. Data are limited on lost to follow-up (LTFU) in high-risk cohorts that have initiated 'Test and Treat'. We describe LTFU in a cohort of women of...
Gespeichert in:
| Veröffentlicht in: | BMC public health 2020-03, Vol.20 (1), p.353-353, Article 353 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 353 |
|---|---|
| container_issue | 1 |
| container_start_page | 353 |
| container_title | BMC public health |
| container_volume | 20 |
| creator | Kamacooko, Onesmus Mayanja, Yunia Bagiire, Daniel Namale, Gertrude Hansen, Christian Holm Seeley, Janet |
| description | Background Immediate uptake of antiretroviral therapy (ART) after an HIV-positive diagnosis (Test and Treat) is now being implemented in Uganda. Data are limited on lost to follow-up (LTFU) in high-risk cohorts that have initiated 'Test and Treat'. We describe LTFU in a cohort of women of high-risk sexual behaviour who initiated ART under "Test and Treat". Methods We performed a retrospective cohort study of participant records at the Good Health for Women Project (GHWP) clinic, a clinic in Kampala for women at high-risk of HIV-infection. We included HIV positive women >= 18 years who initiated ART at GHWP between August 2014 and March 2018. We defined LTFU as not taking an ART refill for >= 3 months from the last clinic appointment among those not registered as dead or transferred to another clinic. We used the Kaplan-Meier technique to estimate time to LTFU after ART initiation. Predictors of LTFU were assessed using a multivariable Cox proportional hazards model. Results The mean (+/- SD) age of the 293 study participants was 30.3 (+/- 6.5) years, with 274 (94%) reporting paid sex while 38 (13%) had never tested for HIV before enrolment into GHWP. LTFU within the first year of ART initiation was 16% and the incidence of LTFU was estimated at 12.7 per 100 person-years (95%CI 9.90-16.3). In multivariable analysis, participants who reported sex work as their main job at ART initiation (Adjusted Hazards Ratio [aHR] =1.95, 95%CI 1.10-3.45), having baseline WHO clinical stage III or IV (aHR = 2.75, 95% CI 1.30-5.79) were more likely to be LTFU. Conclusion LTFU in this cohort is high. Follow up strategies are required to support women on Test and Treat to remain on treatment, especially those who engage in sex work and those who initiate ART at a later stage of disease. |
| doi_str_mv | 10.1186/s12889-020-8439-9 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2378897697</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A618738483</galeid><doaj_id>oai_doaj_org_article_c263b89805ff4ea5b35636fc8d082b1f</doaj_id><sourcerecordid>A618738483</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-694575782c70068a8f9952adb08048cbd03a5045647506ef34c925d3fbbafb093</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEoqXwA7ggq1yQIMWfsXNBqlZ8VFSCAz1bjmNnXRJ7aztdOPPHcdiytIgD8sHW-JnXM-O3qp4ieIKQaF4nhIVoa4hhLShp6_ZedYgoRzWmTNy_dT6oHqV0CSHiguGH1QHBSBDO2sPqx-doeqdziAkEC8aQMsgB2DCOYVvPG-A8UOA4mxJXvgc5GpWPwSaGIappMkBNwQ9A9fOYwTZMxoOty2uwdsO6ji59Bcl8m9UIOrNW1y7ERfCjmjZqVK_AxVA01ePqgVVjMk9u9qPq4t3bL6sP9fmn92er0_Naswbmumkp44wLrDmEjVDCti3Dqu-ggFTorodEMUhZQzmDjbGE6hazntiuU7aDLTmqzna6fVCXchPdpOJ3GZSTvwIhDlLF7PRopMYN6UQrILOWGsU6whrSWC16KHCHbNF6s9PazN1kem18jmq8I3r3xru1HMK15JCXqpdiXtwIxHA1l_HKySVtxlF5E-YkMeHlb3nT8oI-_wu9DHP0ZVQL1SKKMW3_UIMqDThvQ3lXL6LytEGCE0EFKdTJP6iyejM5HbyxrsTvJKBdgo4hpWjsvkcE5eJCuXOhLC6UiwvlUsqz28PZZ_y2XQFe7oCt6YJN2hmvzR6DEDKMCOG0nCAutPh_euWyyi74VZh9Jj8BLyj3SA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2379142249</pqid></control><display><type>article</type><title>Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SpringerNature Journals</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>PubMed Central</source><source>Web of Science - Social Sciences Citation Index – 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>Springer Nature OA/Free Journals</source><creator>Kamacooko, Onesmus ; Mayanja, Yunia ; Bagiire, Daniel ; Namale, Gertrude ; Hansen, Christian Holm ; Seeley, Janet</creator><creatorcontrib>Kamacooko, Onesmus ; Mayanja, Yunia ; Bagiire, Daniel ; Namale, Gertrude ; Hansen, Christian Holm ; Seeley, Janet</creatorcontrib><description>Background Immediate uptake of antiretroviral therapy (ART) after an HIV-positive diagnosis (Test and Treat) is now being implemented in Uganda. Data are limited on lost to follow-up (LTFU) in high-risk cohorts that have initiated 'Test and Treat'. We describe LTFU in a cohort of women of high-risk sexual behaviour who initiated ART under "Test and Treat". Methods We performed a retrospective cohort study of participant records at the Good Health for Women Project (GHWP) clinic, a clinic in Kampala for women at high-risk of HIV-infection. We included HIV positive women >= 18 years who initiated ART at GHWP between August 2014 and March 2018. We defined LTFU as not taking an ART refill for >= 3 months from the last clinic appointment among those not registered as dead or transferred to another clinic. We used the Kaplan-Meier technique to estimate time to LTFU after ART initiation. Predictors of LTFU were assessed using a multivariable Cox proportional hazards model. Results The mean (+/- SD) age of the 293 study participants was 30.3 (+/- 6.5) years, with 274 (94%) reporting paid sex while 38 (13%) had never tested for HIV before enrolment into GHWP. LTFU within the first year of ART initiation was 16% and the incidence of LTFU was estimated at 12.7 per 100 person-years (95%CI 9.90-16.3). In multivariable analysis, participants who reported sex work as their main job at ART initiation (Adjusted Hazards Ratio [aHR] =1.95, 95%CI 1.10-3.45), having baseline WHO clinical stage III or IV (aHR = 2.75, 95% CI 1.30-5.79) were more likely to be LTFU. Conclusion LTFU in this cohort is high. Follow up strategies are required to support women on Test and Treat to remain on treatment, especially those who engage in sex work and those who initiate ART at a later stage of disease.</description><identifier>ISSN: 1471-2458</identifier><identifier>EISSN: 1471-2458</identifier><identifier>DOI: 10.1186/s12889-020-8439-9</identifier><identifier>PMID: 32183759</identifier><language>eng</language><publisher>LONDON: Springer Nature</publisher><subject>Adult ; Adults ; Anti-Retroviral Agents - therapeutic use ; Antiretroviral agents ; Antiretroviral therapy ; Counseling ; Diseases ; Dosage and administration ; Drug therapy ; Female ; Hazard assessment ; Health ; Health aspects ; Health hazards ; Health risks ; Highly active antiretroviral therapy ; HIV ; HIV infections ; HIV Infections - diagnosis ; HIV Infections - drug therapy ; HIV Infections - epidemiology ; HIV tests ; Human immunodeficiency virus ; Humans ; Infections ; Life Sciences & Biomedicine ; Loss to follow-up; sub-Saharan Africa ; Lost to Follow-Up ; Medication Adherence - statistics & numerical data ; Prevention ; Program Evaluation ; Proportional Hazards Models ; Public health ; Public, Environmental & Occupational Health ; Retention ; Retrospective Studies ; Risk ; Risk taking ; Science & Technology ; Sex ; Sex Work - statistics & numerical data ; Sexual behavior ; Sexually transmitted diseases ; Statistical models ; STD ; Studies ; Time ; Uganda - epidemiology ; Universal test and treat ; Women ; Women at high-risk ; Women's health</subject><ispartof>BMC public health, 2020-03, Vol.20 (1), p.353-353, Article 353</ispartof><rights>COPYRIGHT 2020 BioMed Central Ltd.</rights><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s). 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>8</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000521337400002</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c560t-694575782c70068a8f9952adb08048cbd03a5045647506ef34c925d3fbbafb093</citedby><cites>FETCH-LOGICAL-c560t-694575782c70068a8f9952adb08048cbd03a5045647506ef34c925d3fbbafb093</cites><orcidid>0000-0002-0583-5272 ; 0000-0002-5949-0097 ; 0000-0003-2048-8990 ; 0000-0002-0414-1818</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079529/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079529/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2115,27929,27930,28253,28254,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32183759$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kamacooko, Onesmus</creatorcontrib><creatorcontrib>Mayanja, Yunia</creatorcontrib><creatorcontrib>Bagiire, Daniel</creatorcontrib><creatorcontrib>Namale, Gertrude</creatorcontrib><creatorcontrib>Hansen, Christian Holm</creatorcontrib><creatorcontrib>Seeley, Janet</creatorcontrib><title>Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda</title><title>BMC public health</title><addtitle>BMC PUBLIC HEALTH</addtitle><addtitle>BMC Public Health</addtitle><description>Background Immediate uptake of antiretroviral therapy (ART) after an HIV-positive diagnosis (Test and Treat) is now being implemented in Uganda. Data are limited on lost to follow-up (LTFU) in high-risk cohorts that have initiated 'Test and Treat'. We describe LTFU in a cohort of women of high-risk sexual behaviour who initiated ART under "Test and Treat". Methods We performed a retrospective cohort study of participant records at the Good Health for Women Project (GHWP) clinic, a clinic in Kampala for women at high-risk of HIV-infection. We included HIV positive women >= 18 years who initiated ART at GHWP between August 2014 and March 2018. We defined LTFU as not taking an ART refill for >= 3 months from the last clinic appointment among those not registered as dead or transferred to another clinic. We used the Kaplan-Meier technique to estimate time to LTFU after ART initiation. Predictors of LTFU were assessed using a multivariable Cox proportional hazards model. Results The mean (+/- SD) age of the 293 study participants was 30.3 (+/- 6.5) years, with 274 (94%) reporting paid sex while 38 (13%) had never tested for HIV before enrolment into GHWP. LTFU within the first year of ART initiation was 16% and the incidence of LTFU was estimated at 12.7 per 100 person-years (95%CI 9.90-16.3). In multivariable analysis, participants who reported sex work as their main job at ART initiation (Adjusted Hazards Ratio [aHR] =1.95, 95%CI 1.10-3.45), having baseline WHO clinical stage III or IV (aHR = 2.75, 95% CI 1.30-5.79) were more likely to be LTFU. Conclusion LTFU in this cohort is high. Follow up strategies are required to support women on Test and Treat to remain on treatment, especially those who engage in sex work and those who initiate ART at a later stage of disease.</description><subject>Adult</subject><subject>Adults</subject><subject>Anti-Retroviral Agents - therapeutic use</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral therapy</subject><subject>Counseling</subject><subject>Diseases</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Hazard assessment</subject><subject>Health</subject><subject>Health aspects</subject><subject>Health hazards</subject><subject>Health risks</subject><subject>Highly active antiretroviral therapy</subject><subject>HIV</subject><subject>HIV infections</subject><subject>HIV Infections - diagnosis</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - epidemiology</subject><subject>HIV tests</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infections</subject><subject>Life Sciences & Biomedicine</subject><subject>Loss to follow-up; sub-Saharan Africa</subject><subject>Lost to Follow-Up</subject><subject>Medication Adherence - statistics & numerical data</subject><subject>Prevention</subject><subject>Program Evaluation</subject><subject>Proportional Hazards Models</subject><subject>Public health</subject><subject>Public, Environmental & Occupational Health</subject><subject>Retention</subject><subject>Retrospective Studies</subject><subject>Risk</subject><subject>Risk taking</subject><subject>Science & Technology</subject><subject>Sex</subject><subject>Sex Work - statistics & numerical data</subject><subject>Sexual behavior</subject><subject>Sexually transmitted diseases</subject><subject>Statistical models</subject><subject>STD</subject><subject>Studies</subject><subject>Time</subject><subject>Uganda - epidemiology</subject><subject>Universal test and treat</subject><subject>Women</subject><subject>Women at high-risk</subject><subject>Women's health</subject><issn>1471-2458</issn><issn>1471-2458</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>ARHDP</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkk1v1DAQhiMEoqXwA7ggq1yQIMWfsXNBqlZ8VFSCAz1bjmNnXRJ7aztdOPPHcdiytIgD8sHW-JnXM-O3qp4ieIKQaF4nhIVoa4hhLShp6_ZedYgoRzWmTNy_dT6oHqV0CSHiguGH1QHBSBDO2sPqx-doeqdziAkEC8aQMsgB2DCOYVvPG-A8UOA4mxJXvgc5GpWPwSaGIappMkBNwQ9A9fOYwTZMxoOty2uwdsO6ji59Bcl8m9UIOrNW1y7ERfCjmjZqVK_AxVA01ePqgVVjMk9u9qPq4t3bL6sP9fmn92er0_Naswbmumkp44wLrDmEjVDCti3Dqu-ggFTorodEMUhZQzmDjbGE6hazntiuU7aDLTmqzna6fVCXchPdpOJ3GZSTvwIhDlLF7PRopMYN6UQrILOWGsU6whrSWC16KHCHbNF6s9PazN1kem18jmq8I3r3xru1HMK15JCXqpdiXtwIxHA1l_HKySVtxlF5E-YkMeHlb3nT8oI-_wu9DHP0ZVQL1SKKMW3_UIMqDThvQ3lXL6LytEGCE0EFKdTJP6iyejM5HbyxrsTvJKBdgo4hpWjsvkcE5eJCuXOhLC6UiwvlUsqz28PZZ_y2XQFe7oCt6YJN2hmvzR6DEDKMCOG0nCAutPh_euWyyi74VZh9Jj8BLyj3SA</recordid><startdate>20200318</startdate><enddate>20200318</enddate><creator>Kamacooko, Onesmus</creator><creator>Mayanja, Yunia</creator><creator>Bagiire, Daniel</creator><creator>Namale, Gertrude</creator><creator>Hansen, Christian Holm</creator><creator>Seeley, Janet</creator><general>Springer Nature</general><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>17B</scope><scope>AOWDO</scope><scope>ARHDP</scope><scope>BLEPL</scope><scope>DTL</scope><scope>DVR</scope><scope>EGQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>M0S</scope><scope>M1P</scope><scope>M7S</scope><scope>PATMY</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0583-5272</orcidid><orcidid>https://orcid.org/0000-0002-5949-0097</orcidid><orcidid>https://orcid.org/0000-0003-2048-8990</orcidid><orcidid>https://orcid.org/0000-0002-0414-1818</orcidid></search><sort><creationdate>20200318</creationdate><title>Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda</title><author>Kamacooko, Onesmus ; Mayanja, Yunia ; Bagiire, Daniel ; Namale, Gertrude ; Hansen, Christian Holm ; Seeley, Janet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-694575782c70068a8f9952adb08048cbd03a5045647506ef34c925d3fbbafb093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Adults</topic><topic>Anti-Retroviral Agents - therapeutic use</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral therapy</topic><topic>Counseling</topic><topic>Diseases</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Hazard assessment</topic><topic>Health</topic><topic>Health aspects</topic><topic>Health hazards</topic><topic>Health risks</topic><topic>Highly active antiretroviral therapy</topic><topic>HIV</topic><topic>HIV infections</topic><topic>HIV Infections - diagnosis</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - epidemiology</topic><topic>HIV tests</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infections</topic><topic>Life Sciences & Biomedicine</topic><topic>Loss to follow-up; sub-Saharan Africa</topic><topic>Lost to Follow-Up</topic><topic>Medication Adherence - statistics & numerical data</topic><topic>Prevention</topic><topic>Program Evaluation</topic><topic>Proportional Hazards Models</topic><topic>Public health</topic><topic>Public, Environmental & Occupational Health</topic><topic>Retention</topic><topic>Retrospective Studies</topic><topic>Risk</topic><topic>Risk taking</topic><topic>Science & Technology</topic><topic>Sex</topic><topic>Sex Work - statistics & numerical data</topic><topic>Sexual behavior</topic><topic>Sexually transmitted diseases</topic><topic>Statistical models</topic><topic>STD</topic><topic>Studies</topic><topic>Time</topic><topic>Uganda - epidemiology</topic><topic>Universal test and treat</topic><topic>Women</topic><topic>Women at high-risk</topic><topic>Women's health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kamacooko, Onesmus</creatorcontrib><creatorcontrib>Mayanja, Yunia</creatorcontrib><creatorcontrib>Bagiire, Daniel</creatorcontrib><creatorcontrib>Namale, Gertrude</creatorcontrib><creatorcontrib>Hansen, Christian Holm</creatorcontrib><creatorcontrib>Seeley, Janet</creatorcontrib><collection>Web of Knowledge</collection><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science - Social Sciences Citation Index – 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Social Sciences Citation Index</collection><collection>Web of Science Primary (SCIE, SSCI & AHCI)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Engineering Database</collection><collection>Environmental Science Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kamacooko, Onesmus</au><au>Mayanja, Yunia</au><au>Bagiire, Daniel</au><au>Namale, Gertrude</au><au>Hansen, Christian Holm</au><au>Seeley, Janet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda</atitle><jtitle>BMC public health</jtitle><stitle>BMC PUBLIC HEALTH</stitle><addtitle>BMC Public Health</addtitle><date>2020-03-18</date><risdate>2020</risdate><volume>20</volume><issue>1</issue><spage>353</spage><epage>353</epage><pages>353-353</pages><artnum>353</artnum><issn>1471-2458</issn><eissn>1471-2458</eissn><abstract>Background Immediate uptake of antiretroviral therapy (ART) after an HIV-positive diagnosis (Test and Treat) is now being implemented in Uganda. Data are limited on lost to follow-up (LTFU) in high-risk cohorts that have initiated 'Test and Treat'. We describe LTFU in a cohort of women of high-risk sexual behaviour who initiated ART under "Test and Treat". Methods We performed a retrospective cohort study of participant records at the Good Health for Women Project (GHWP) clinic, a clinic in Kampala for women at high-risk of HIV-infection. We included HIV positive women >= 18 years who initiated ART at GHWP between August 2014 and March 2018. We defined LTFU as not taking an ART refill for >= 3 months from the last clinic appointment among those not registered as dead or transferred to another clinic. We used the Kaplan-Meier technique to estimate time to LTFU after ART initiation. Predictors of LTFU were assessed using a multivariable Cox proportional hazards model. Results The mean (+/- SD) age of the 293 study participants was 30.3 (+/- 6.5) years, with 274 (94%) reporting paid sex while 38 (13%) had never tested for HIV before enrolment into GHWP. LTFU within the first year of ART initiation was 16% and the incidence of LTFU was estimated at 12.7 per 100 person-years (95%CI 9.90-16.3). In multivariable analysis, participants who reported sex work as their main job at ART initiation (Adjusted Hazards Ratio [aHR] =1.95, 95%CI 1.10-3.45), having baseline WHO clinical stage III or IV (aHR = 2.75, 95% CI 1.30-5.79) were more likely to be LTFU. Conclusion LTFU in this cohort is high. Follow up strategies are required to support women on Test and Treat to remain on treatment, especially those who engage in sex work and those who initiate ART at a later stage of disease.</abstract><cop>LONDON</cop><pub>Springer Nature</pub><pmid>32183759</pmid><doi>10.1186/s12889-020-8439-9</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-0583-5272</orcidid><orcidid>https://orcid.org/0000-0002-5949-0097</orcidid><orcidid>https://orcid.org/0000-0003-2048-8990</orcidid><orcidid>https://orcid.org/0000-0002-0414-1818</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1471-2458 |
| ispartof | BMC public health, 2020-03, Vol.20 (1), p.353-353, Article 353 |
| issn | 1471-2458 1471-2458 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2378897697 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SpringerNature Journals; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; PubMed Central; Web of Science - Social Sciences Citation Index – 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; Springer Nature OA/Free Journals |
| subjects | Adult Adults Anti-Retroviral Agents - therapeutic use Antiretroviral agents Antiretroviral therapy Counseling Diseases Dosage and administration Drug therapy Female Hazard assessment Health Health aspects Health hazards Health risks Highly active antiretroviral therapy HIV HIV infections HIV Infections - diagnosis HIV Infections - drug therapy HIV Infections - epidemiology HIV tests Human immunodeficiency virus Humans Infections Life Sciences & Biomedicine Loss to follow-up sub-Saharan Africa Lost to Follow-Up Medication Adherence - statistics & numerical data Prevention Program Evaluation Proportional Hazards Models Public health Public, Environmental & Occupational Health Retention Retrospective Studies Risk Risk taking Science & Technology Sex Sex Work - statistics & numerical data Sexual behavior Sexually transmitted diseases Statistical models STD Studies Time Uganda - epidemiology Universal test and treat Women Women at high-risk Women's health |
| title | Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T13%3A48%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predictors%20of%20lost%20to%20follow-up%20in%20a%20%22test%20and%20treat%22%20programme%20among%20adult%20women%20with%20high-risk%20sexual%20behavior%20in%20Kampala,%20Uganda&rft.jtitle=BMC%20public%20health&rft.au=Kamacooko,%20Onesmus&rft.date=2020-03-18&rft.volume=20&rft.issue=1&rft.spage=353&rft.epage=353&rft.pages=353-353&rft.artnum=353&rft.issn=1471-2458&rft.eissn=1471-2458&rft_id=info:doi/10.1186/s12889-020-8439-9&rft_dat=%3Cgale_proqu%3EA618738483%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2379142249&rft_id=info:pmid/32183759&rft_galeid=A618738483&rft_doaj_id=oai_doaj_org_article_c263b89805ff4ea5b35636fc8d082b1f&rfr_iscdi=true |